To further determine the relationship between ZKSCAN3 and the prognosis of other cohort HCC patients, 182 patients with ZKSCAN3 high expression and 182 patients with ZKSCAN3 low expression were analyzed in GEPIA (P < 0.05, Fig. 1f). This evidence concerns the gene ZKSCAN3 and hepatocellular carcinoma.